Search results
Author(s):
Oliver Weingärtner
,
Added:
2 years ago
Join us for this live broadcast where faculty will ensure physicians based in Malaysia are aware of the importance of risk stratification in relation to secondary prevention and how this is dealt with in the recent ESC guidance and why it's important. The faculty will make a distinct comparison between the ESC guidelines and what the Malaysian guidelines say is central to this, including why is…
View more
Catherine R Weinberg
Job title: Director of the Adult Congenital Heart Disease Program and High Risk Cardiovascular Obstetrics
Author
Author(s):
Jillian Riley
Added:
3 years ago
The specialised role of the heart failure nurse rose to prominence during the 1990s. Studies of heart failure disease management reported a reduction in the risk of hospital readmission in services with structured follow up that focused on the optimisation of therapy, out-patient follow up, education for self-care and the coordination of care.1 Nurses had already established their role in the…
View more
Author(s):
Sarah H Cross
,
Arif H Kamal
,
Donald H Taylor Jr
,
et al
Added:
3 years ago
Heart failure (HF) is estimated to affect 26 million people worldwide and is responsible for an annual global economic burden of US$108 billion.1,2 An ageing population and a reduction in mortality from other conditions such as acute MI are expected to result in an increased HF prevalence throughout much of the world.1,3–6 The prevalence of HF has particularly increased among those aged 85 years…
View more
Author(s):
Paul Kalra
Added:
10 months ago
ESC-HFA 23 – Prof Paul Kalra (Portsmouth Hospitals NHS Trust, UK) joins us onsite to discuss the IRONMAN trial (NCT02642562).
The IRONMAN trial aimed to study the effectiveness of intravenous iron in patients with heart failure and iron deficiency when compared to standard care. It showed that administration of IV FDI led to lower rates of recurrent heart failure hospitalisations and…
View more
Author(s):
Sunil K Nadar
,
Muhammad Mujtaba Shaikh
Added:
3 years ago
The National Institutes of Health Biomarkers Definitions Working Group define a biomarker as “a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention”.1 Biomarkers have become increasingly important in current medical practice as they offer an easy way to either…
View more
Author(s):
Rekha V Thammana
,
Sarah J Goodlin
Added:
2 years ago
Implementing HF Guidelines with Collaborative Care
Video Series
Heart Failure in Primary Care
Author(s):
Loreena Hill
,
Anne McNulty
,
James McMahon
,
et al
Added:
2 months ago
Article
Author(s):
Aniket S Rali
,
Ahmed M Salem
,
Melat Gebre
,
et al
Added:
3 years ago